An unprecedented contribution in scope for the development of the field of cancer research and treatment was awarded by the American couple Susan and Henry Samueli to the Davidoff Center for Cancer Treatment in “Bilinson”. With the help of the donation, in the amount of NIS 120 million and additional support from “Klelit”, a Samuel Institute for Cancer Research and Innovation will be established at the Davidoff Center.
More on a similar matter
According to Dr. Eitan Wertheim, director of the Bilinson and Sharon hospitals, this is a “rare donation, the largest received at ‘Bilinson’ and not intended for the building, thanks to which we are going to change the face of cancer medicine in the world.”
Prof. Gal Markel, partner, founder and chairman of the Samueli Institute for Cancer Research and Innovation and director of the Davidoff Center in Bilinson. Photo: Elad Malka
Prof. Gal Markel, director of the Davidoff Center and chairman of the Samueli Institute for Cancer Research and Innovation, said: “The Samueli Institute will combine artificial intelligence experts, behavioral researchers, cancer scientists, the unique clinical team of the Davidoff Center, together with one of the largest Big Data databases in the world that are available to us thanks to general Together we will decipher the map of cancer and its treatment anew. We will generate new insights based on information axes that have not been examined so far, which will be needed for the development of original technological approaches and solutions or in partnership with experts and industries from all over the world.”
The donors, Dr. Henry Samueli, founder and chairman of the board of directors of “Broadcom”, and Dr. Susan Samueli, who is engaged in international philanthropic activities to promote health, believe that the next significant leap in cancer research will result from a scientific fusion of the human approach at the center together with research medicine and translational biology, which will be accelerated through breakthrough artificial intelligence technology. “Our expectation,” they say, “is that the Samueli Institute will challenge existing perceptions and create a better future for cancer patients. The real benchmark for the institute’s success will be the adoption of our innovation in other leading institutes around the world.”
